Substitute House Bill No. 6855, also known as Public Act No. 25-101, establishes new regulations for the sale of hemp flower and the operation of nonresident pharmacies in Connecticut. Effective October 1, 2025, the bill permits individuals not licensed as cannabis establishments or moderate-THC hemp product vendors to sell hemp flower under specific conditions, including in-person assistance and age verification for purchasers. It also revises definitions related to cannabis and hemp regulation to align with existing statutes. For nonresident pharmacies, starting January 1, 2026, the bill requires registration with the state and annual operational reports, while streamlining language by deleting certain phrases. It mandates compliance with sterile compounding standards and inspection reports from government agencies or qualified third parties, enhancing oversight of pharmacies delivering medications into Connecticut.

The bill further amends the classification of marijuana under controlled substance regulations, designating it as a schedule II controlled substance and introducing new classifications for synthetic cannabinoids and other substances. It updates the process for issuing written certifications for the palliative use of marijuana, allowing for varying durations and temporary extensions by licensed dispensaries. Additionally, it clarifies the definition of "Backer" to exclude certain financial institutions and individuals with limited investment interests, and mandates standardized signage for cannabis establishments. The legislation also introduces new regulations for moderate-THC hemp products, including age verification requirements and adherence to testing standards, while updating definitions related to opioid drugs and establishing protocols for dispensing opioid antagonists. Overall, the bill aims to enhance regulatory oversight and consumer protection within the cannabis and hemp industries.

Statutes affected:
Raised Bill: 20-627
GL Joint Favorable Substitute: 20-627
File No. 618: 20-627
Public Act No. 25-101: 20-627